Dr. Susan Panullo on Optune Versus Salvage Chemotherapy in Glioblastoma
January 29th 2016Susan Panullo, MD, director, Neuro-oncology, director, Neurosurgical Radiosurgery, Weill Cornell Brain and Spine Center, discusses the improvement in quality of life in patients with glioblastoma treated with Optune (NovoTTF-100A).